Minerva Neurosciences Inc NERV 深 沪
交易中 11-05 09:57:22 美东时间
2.525
-0.045
-1.75%
华盛通- 最 高2.66
- 今 开2.66
- 成交量 1.50万股
- 最 低 2.525
- 昨 收 2.57
- 总市值 1.21亿
- 52周最高 8.80
- 市盈率 静 --
- 换手率 0.03%
- 52周最低 1.96
- 委 比 21.03%
- 总股本 4774.76万
- 历史最高 126.72
- 量 比 2.26
- 振 幅 5.25%
- 历史最低 1.15
- 每 手 1
- 风险率 1.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Minerva Neurosciences收涨0.21%，成交额57.36万美元
11月4日，Minerva Neurosciences（NERV）收涨0.21%，报2.35美元，成交额57.36万美元，市值1.12亿美元。 行情数据 • 开...
11-04 07:56
Minerva Neurosciences to Host In-Person KOL Event to Discuss Roluperidone for Negative Symptoms of Schizophrenia
Minerva Neurosciences, Inc. will host an event on November 12, 2026, in New York to discuss roluperidone's potential in treating schizophrenia's negative symptoms. Experts Christoph Correll, Brian Kirkpatrick, and Gregory Strauss will join company management to discuss new analysis, Phase 3 trial updates, and other developments. The event will include a live Q&A and webcast. Roluperidone is an investigational monotherapy for negative symptoms lik...
10-28 11:00
Minerva Neurosciences收跌4.35%，成交额38.43万美元
10月27日，Minerva Neurosciences（NERV）收跌4.35%，报2.2美元，成交额38.43万美元，市值1.05亿美元。 行情数据 • 开...
10-27 07:01
Minerva Neurosciences收跌2.89%，成交额20.14万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:03
Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
Minerva Neurosciences, Inc. announced that its management will participate in two upcoming investor conferences: the Wells Fargo Healthcare Conference on September 8 and the 2026 Cantor Global Healthcare Conference on September 9, both in New York. The events will include 1x1 meetings and a fireside chat. Interested investors can contact conference representatives or access the live webcast via the company's website. Minerva Neurosciences is focu...
08-28 12:00
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
This Capricor Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Stifel analyst Jonathan Siegmann upgraded Intuitive Machines Inc (NASDAQ:LUNR) from Hold to Buy a...
08-14 20:55
Jefferies Upgrades Minerva Neurosciences to Buy, Raises Price Target to $10
Jefferies analyst Biren Amin upgrades Minerva Neurosciences (NASDAQ:NERV) from Hold to Buy and raises the price target from $7.5 to $10.
08-14 20:41
Minerva Neurosciences Q2 Adj. EPS $(0.10) Beats $(0.12) Estimate
Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 9.09 percent. This is a 76.74 percent increase over losses of $(0.43) per share from the same period last year.
08-07 19:42
